orantinib has been researched along with pha 680632 in 1 studies
| Studies (orantinib) | Trials (orantinib) | Recent Studies (post-2010) (orantinib) | Studies (pha 680632) | Trials (pha 680632) | Recent Studies (post-2010) (pha 680632) |
|---|---|---|---|---|---|
| 110 | 19 | 36 | 20 | 0 | 14 |
| Protein | Taxonomy | orantinib (IC50) | pha 680632 (IC50) |
|---|---|---|---|
| Aurora kinase A | Homo sapiens (human) | 0.027 | |
| LIM domain kinase 1 | Homo sapiens (human) | 0.4914 | |
| LIM domain kinase 2 | Homo sapiens (human) | 7.9433 | |
| Aurora kinase B | Homo sapiens (human) | 0.108 | |
| Aurora kinase C | Homo sapiens (human) | 0.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, HG; Borisa, AC | 1 |
1 review(s) available for orantinib and pha 680632
| Article | Year |
|---|---|
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies.
Topics: Animals; Antineoplastic Agents; Aurora Kinases; Cell Proliferation; Clinical Trials as Topic; Humans; Molecular Structure; Protein Kinase Inhibitors; Small Molecule Libraries | 2017 |